 |
인쇄하기
취소
|
Handok launches Tracleer in pulmonary arterial hypertension
Handok Pharm announced on November 1 that Tracleer tablet (bosentan) is now available upon prescription to all patients in Korea.
In March of this year, the Korea Food and Drug Administration granted formal approval of Tracleer for the treatment of all forms of pulmonary arterial hypertension (PAH; WHO class III and IV), a chronic, life-threatening disorder which severely compromises the fun...
In March of this year, the Korea Food and Drug Administration granted formal approval of Tracleer for the treatment of all forms of pulmonary arterial hypertension (PAH; WHO class III and IV), a chronic, life-threatening disorder which severely compromises the fun...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.